NUVB
Nuvation Bio Inc.
Biotechnology · Healthcare · United States
6.10
close · 2026-08-13
value
18
cheaper than peers18
quality
40
stronger fundamentals40
ranked against
Biotechnology (commercial)
value
quality
101 peerswide variation
Value inputs
| measure | company | vs peers |
| price to sales | 13.64× | 48 |
| price to book | 8.40× | 28 |
| forward P/E | 128.40× | 10 |
3 of 12 measures available
Quality inputs
| measure | company | vs peers |
| revenue growth | 555.6% | 92 |
| return on equity | -47.8% | 39 |
| operating margin | -161.1% | 38 |
| debt to equity | 164.0% | 16 |
4 of 4 measures available
Facts
| market cap | $2B |
| free cash flow | -$111.7M |
| employees | 298 |
| first trade | 2020-08-26 |
| next earnings | 2026-08-06 |
| fundamentals updated | 2026-08-07 |